دورية أكاديمية
Phase II study of cemiplimab, a human monoclonal anti-PD-1, in patients with advanced basal cell carcinoma (BCC) who experienced progression of disease on, or were intolerant of prior hedgehog pathway inhibitor (HHI) therapy
| العنوان: | Phase II study of cemiplimab, a human monoclonal anti-PD-1, in patients with advanced basal cell carcinoma (BCC) who experienced progression of disease on, or were intolerant of prior hedgehog pathway inhibitor (HHI) therapy |
|---|---|
| المؤلفون: | Lewis, K.D., Fury, M.G., Stankevich, E., Mathias, M., Mohan, K.K., Li, S., Nunnink, K., Perry, C., Narwal, A. |
| المصدر: | Annals of Oncology ; volume 29, page viii440 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2018 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/annonc/mdy288.111 |
| الإتاحة: | https://doi.org/10.1093/annonc/mdy288.111Test https://api.elsevier.com/content/article/PII:S0923753419496956?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753419496956?httpAccept=text/plainTest http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy288.111/26138280/mdy288.111.pdfTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.3FAE75E |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdy288.111 |
|---|